The Mitochondrial Driver
Mitochondrial dysfunction stands as the universal hallmark of reproductive aging. In both sperm and oocytes, the accumulation of mtDNA mutations and the subsequent decline in oxidative phosphorylation capacity (ATP production) result in failure of fertilization, embryo cleavage, and implantation.
In males, this is exacerbated by oxidative stress, often linked to systemic conditions like obesity and diabetes. In females, the depletion of the primordial follicle pool, coupled with the bioenergetic failure of remaining oocytes, dictates the decline in reproductive potential.
Clinical Interventions
For ovarian insufficiency, In Vitro Activation (IVA) represents the most mechanistic approach. By fragmenting cortical tissue, clinicians disrupt the Hippo pathway, which normally suppresses follicle activation. This 'jumpstarts' dormant follicles, offering a window of opportunity for retrieval.
Conversely, the use of PRP is the most prevalent—though currently less rigorously validated—clinical intervention. While pilot data suggests a boost in AMH (Anti-Müllerian Hormone), its efficacy in improving true live-birth rates remains debated due to a lack of large-scale, placebo-controlled trials.